Tao has an international law degree from the East China University of Political Science and Law. He also holds two masters degrees in law from the University of Milan, Italy and the University of the Basque Country in Bilbao, Spain. During 2017 and 2018, Tao interned in both the private sector and the judicial system in Shanghai. He has a strong interest in exploring the international legal arena.
Tao’s focus is on policy and regulatory issues in China and Taiwan.
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.
Do the Novel Food regulations in Europe affect your business?
CBD as a Novel Food: the future for edibles in Europe
This new CBD-Intel report examines key aspects and drivers of the edibles market itself before looking in detail at the Novel Food regulations, both at EU level and in non-EU markets: notably the UK, as well as Switzerland and Norway.
Questions it considers and answers include whether CBD really is novel, whether approvals are likely to be generic or applicant-specific, how the Novel Food Catalogue and RASFF operate, and the costs of Novel Food applications.
This report also includes a 1-hour consultation call with CBD-Intel’s analyst team.